USANA Health Sciences Shares Plunge On Q2 Preliminary Results, FY22 Guidance Cut

USANA Health Sciences, Inc.  (NYSE: USNA ) shares slid in the post-market session after it reported preliminary second-quarter results and updated its FY22 outlook . USANA anticipates Q2 net sales will be ~$265 million (compared to $337 million in 2Q21). It expects earnings per share of ~$1.05 (compared to $1.87 in 2Q21). “Our sales performance during the second quarter was below expectations, as COVID-related lockdowns, restrictions, and other disruptions continued in mainland China and other ... Full story available on Benzinga.com